activating glp-1 receptors receptor activation induces several second messenger cell Glucagon-like Peptide-1 Receptor (GLP-1R) Signaling:

Baseline characteristics of included individuals Before matching, the combination (GLP-1RA + SGLT2i) and monotherapy (SGLT2i) groups showed significant differences (Table 1)

Other similar options include, amphetamines, Meridia, bariatric surgery, worms, malaria, tuberculosis, etc

It may reduce insulin release in response to glucose by inhibiting aldose reductase (165)

Recent reports have connected Ozempic to fatal adverse events, with notable cases including sudden deaths linked to gastroparesis (or stomach paralysis), bowel obstruction, and, in rare cases, life-threatening conditions such as pancreatitis and gallbladder disease